The aim of the present paper was to investigate the effect of Shengjie Tongyu granule on vascular remodeling in atherosclerotic mice and the relevant underlying mechanism. Sixty male ApoE-gene-knockout mice, fed a high-fat diet from 6 weeks of age, were randomized into a Shengjie Tongyu granule group (4.00 g/kg/d), a simvastatin group (9.01 mg/kg/d), and a control group (normal saline: 0.2 mL/d). At the ages of 30 and 40 weeks, we sacrificed the mice for various measurements. The results show that treatment with Shengjie Tongyu granule and simvastatin significantly decreased lumen and plaque areas in the aortic root at 30 and 40 weeks of age, decreased grade II elastic fiber lesions in the ascending aorta at 30 weeks of age, and decreased both grade II and III lesions at 40 weeks of age, compared to controls. The content of superoxide anions, and expression of MOMA-2, plasma ICAM-1, and NFκB p50 in 30-and 40-week-old mice in the Shengjie Tongyu granule and simvastatin groups were also significantly reduced compared to the control group. In conclusion, Shengjie Tongyu granule has a clear inhibitory effect on vascular remodeling and on inflammatory pathways in ApoE-gene-knockout mice.
Introduction
Atherosclerosis is generally considered to be an inflammatory proliferative disease. Vascular remodeling, a dynamic process of conformational changes in the vasculature resulting from cell proliferation, necrosis and migration; and extracellular matrix synthesis and degradation, plays an important role in the development of atherosclerosis, inflammation and oxidation play an important role in vascular remodeling [1, 2] . In atherosclerotic vessels undergoing remodeling, increased numbers of inflammatory cells including macrophages and T lymphocytes, increased matrix metalloproteinase (MMP) expression, decreased vascular smooth muscle mass, decomposition of elastin and collagen, and an attenuated vascular wall, all closely related to changes in the redox state of the cells, are found [3] . Production of local reactive oxygen species (superoxide anions, nitric oxide, etc.) can increase low-density lipoprotein (LDL) oxidation, local inflammation, vascular adventitial fibroblast proliferation, and extracellular matrix synthesis. Local reactive oxygen species can also directly activate NFκB and stimulate the expression of NFκB-dependent genes, including genes of proinflammatory factors related to atherosclerosis, such as intercellular adhesion molecule 1 (ICAM-1). The increase in expression of proinflammatory genes then further increases the atherosclerotic process and vascular remodeling [3, 4] .
Because vascular remodeling plays an important role in atherosclerotic disease and patient prognosis, exploration of methods to improve the vascular remodeling process has been a subject of intensive research in recent years [5, 6] . Statins are one type of substance shown to have a beneficial effect on vascular remodeling. The mechanism of simvastatin in improving vascular remodeling has been ascribed to its multiple actions, especially its anti-inflammatory properties, rather than to its direct lipid-lowering effect [7] .
Chinese herbal medicines are known to be effective in treating atherosclerosis [8] , and their effects in improving vascular remodeling warrant further exploration. Shengjie Tongyu granule, on the basis of Sheng Xian Tang introduced by a famous physician in the Qing Dynasty, contains 2 Evidence-Based Complementary and Alternative Medicine a number of bioactive components. Of these components, astragalus polysaccharide exerts an antiatherosclerotic effect through inhibiting TNF-alpha-induced activation of foam cells [9] , and timosaponin affects calcium mobilization in vascular endothelial cells and smooth muscle cells and regulates vascular tension [10] , and inhibits superoxide production and platelet aggregation after neutrophil activation [11] [12] [13] . Therefore, it is a reasonable hypothesis that Shengjie Tongyu granule might be efficacious for treating atherosclerotic diseases. Because the Shengjie Tongyu granule has antiatherosclerotic, anti-inflammatory, and antiplatelet aggregation effects, we speculated that the antiatherosclerotic effect of Shengjie Tongyu granule is related to its antiinflammatory actions.
The ApoE-gene-knockout mice mouse is a suitable animal model for study of atherosclerosis. ApoE is a constituent of plasma lipoproteins and serves as a ligand for cell-surface lipoprotein receptors such as the LDL-receptor (LDLr) that promote the uptake of atherogenic particles from the circulation. Homozygous deletion of the ApoE gene in mice results in a pronounced increase in the levels of plasma LDL and very low-density lipoprotein, due to the failure of LDLrand lipoprotein receptor-related protein-mediated clearance of these lipoproteins. The most clearly observable phenotype of ApoE-gene-knockout mice is the spontaneous development of atherosclerotic lesions [14] which highly resemble human atherosclerosis [15] combined with the spontaneous development of arterial vascular remodeling [16] .
In the current study, we used ApoE-gene-knockout mice as an animal model of atherosclerosis and simvastatin as a positive control to investigate the inhibitory effect of Shengjie Tongyu granule on vascular remodeling in atherosclerotic arteries and to see if the mechanism of its effect is related to a decrease in oxidation and inflammation.
Materials and Methods
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1. Animals. 6-week-old male ApoE-gene-knockout mice (strain C57/6J, introduced from The Jackson Laboratory, USA, and bred by the Laboratory Animal Center of Beijing University) weighing 19 to 21 g were fed from the age of 6 weeks onward with a high-fat diet containing 21% (wt/wt) fat and 1.25% (wt/wt) cholesterol that was sterilized by irradiation ( 60 Coy). Mice were raised at clean level II, room temperature of 22 to 24
• C, 50% relative humidity, and a 12-hour light/dark cycle. The study was approved by the Animal Research Committee of the China-Japan Friendship Hospital. 
Evaluation of Aortic Vascular Remodeling
Aorta Preparation. Mice were killed after anesthesia with sodium barbital, and hearts and aortas were harvested under sterile conditions. In each group, ten aortas were fixed in 10% formalin for histological and immunohistochemical observation, and the other ten aortas were prepared as frozen slices and immediately stored in a −80
• C freezer for Western blotting.
Evaluation of Vascular Remodeling in the Aortic
Root. Aortic slices were collected consecutively from the beginning of the aortic valve to the point where the aortic valve disappeared (50 μm length and 5 μm slice thickness). Average plaque areas, lumen areas, and their ratios were measured in these slices after hematoxylin andeosin (HE) staining. 
Evaluation of Vascular
Biochemical Determinations
Determination of Blood Lipids and Serum Soluble ICAM-1 Level. At 30 and 40 weeks of age, after the mice in each group were killed, blood from the inferior vena cava was collected, and the serum separated and stored at −80
• C. Total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were measured by enzymatic assay. Soluble ICAM-1 was measured using an ELISA reagent kit according to the manufacturer's instructions.
Determination of Collagen Contents. The collagen contents in the ascending aorta in ApoE-gene-knockout mice were measured by an immunohistochemical staining method.
Monocyte/Macrophage Antibody-2 (MOMA-2) and Superoxide Anion Determination.
For the determination of MOMA-2, frozen slices of aorta were fixed in acetone and incubated with rat monoclonal anti-mouse MOMA-2 (Abcam, UK) at a dilution of 1 : 50 at room temperature. After washing, the slices were incubated in the dark with fluoresce in isothiocyanate (FITC)-labeled secondary antibody at room temperature. The results were observed under a fluorescence microscope (Nikon 90i, Japan). For determination of superoxide anions, the slices were incubated with superoxide anion probe (Abcam, UK, 2 μmol/L) for 30 minutes, washed four times with PBS, and examined with a fluorescence microscope (Nikon 90i, Japan). Images were analyzed by an investigator who was blinded to the study protocol, using Image-ProP1us 5.1 software. Expression levels were quantified by calculating average optical density values.
Western Blot Analysis of Aortic of NFκB p50. The aortic arch from each group was added to the protein lysis buffer and homogenized. Soluble proteins were recovered using centrifugation. The soluble proteins then underwent SDS polyacrylamide gel electrophoresis, and the separated proteins were transferred to polyvinylidene fluoride (PVDF) membranes. The membrane was blocked with 3% skim milk powder in washing buffer solution (10 mmol/L, Tris-HCl, and pH 7.6) for 1 hour at room temperature, followed by incubation overnight at 4
• C with rabbit anti-mouse NFκB P50 polyclonal antibody (1 : 600 dilution; Cell Signaling, USA), and goat anti-rabbit antibody (1 : 600) for 1.5 hours at room temperature successively. After each incubation, four 10-minute washes with PBS were performed. Thereafter, an Opti-4CN Substrate Kit, a chemiluminescence enhancer, was used to develop color in PVDF membranes. After incubation at room temperature for 20 minutes, a laser densitometer (Bio-Rad, USA) was used for gray-scale analysis of NFκB P50 expression.
Statistical Analysis.
Continuous variables are expressed as mean and standard deviation. Two-way ANOVA was performed to evaluate the effect of age and treatment and the interaction effect between age and treatment. Post hoc tests were performed by using Scheffe's method. The statistical significance level was set as 0.05. Statistical analyses were performed with SPSS 15.0 statistics software (SPSS Inc., Chicago, IL, USA).
Results
Mortality.
No mice died in the period before 30 weeks of age; however, six mice died in the period between 30 and 40 weeks of age. No significant difference in mortality between groups (2 mice died in each group) was observed.
Progression of Atherosclerosis in Control
Mice. In the control mice, as expected from the ApoE-gene-knockout mice genotype, plasma lipid concentrations increased with time and were significantly higher in 40-week-old than in 30-week-old mice. Vascular remodeling also increased, as shown by the increase in luminal area and percent of luminal area occupied by plaque, the deterioration of elastic fibers, and the shift from type I to type III collagen. Accompanying this increase in vascular remodeling was an increase in the inflammatory biomarkers, superoxide anion, ICAM-1, MOMA-2, and NFκB.
Lipid Levels, Kidney, and Liver
Function. Blood lipid levels increased with time in all groups and were significantly higher at 40 weeks than at 30 weeks. Neither of the two treatments had any significant effect on blood lipid levels at either time period (Table 1) . Nor did either of the treatments have any significant effects on kidney of liver function (Table 2) .
Cardiac Remodeling
Lumenal and Plaque Areas.
Lumenal area at the base of the aorta increased significantly with time in all groups, as did plaque area, both when measured alone or as a percentage of the luminal area (Figure 2 ). Mice treated with Figure 3 shows the representative images of lumen and plaque in different groups at 30 and 40 weeks. * Indicates a significant difference compared to the control group.
Elastic Fibers and Collagen.
§ Indicates a significant difference compared to the 30-week group. Lumenal area was measured using the outer elastic fiber as the boundary, and plaque area was measured from the outer layer of elastic fiber to the inside of the lumen. Loss rate as per cent of lumenal area was calculated as follows: loss rate = (plaque area / lumen area) × 100%.
P values < 0.001), and a smaller increase in damaged fibers (stage II: 22.5 and 22.4 versus 40.9, stage III: 4.2 and 3.6 versus 16.5, P values < 0.001) than control mice ( Figure 5 ).
Collagens showed a shift from type I to type III collagen at 40 weeks in all groups, but this shift was smaller in simvastatin and Shengjie Tongyu granule-treated animals ( Figure 6 ). Figure 7 shows representative illustrations of Shengjie Tongyu, simvastatin, and control collagen content at 30 weeks (A, B, and C) and 40 weeks (D, E, and F).
Markers of Inflammation
ICAM-1.
ICAM-1 levels increased with time in all groups and were significantly higher at 40 weeks than at 30 weeks. Simvastatin and Shengjie Tongyu granule treatment decreased ICAM-1 levels at both time periods (P < 0.001). At 30, but not at 40 weeks, Shengjie Tongyu granule treatment resulted in significantly lower levels of ICAM-1 than simvastatin treatment (Figure 8 ).
Superoxide Anion.
Superoxide anion levels increased with time in all groups and were significantly lower in the simvastatin and Shengjie Tongyu groups than in the control group (30 weeks: 1.2 and 0.9 versus 3.9, 40 weeks: 2.1 and 1.7 versus 7.6, P values < 0.001). They were also lower in the Shengjie Tongyu group than in the simvastatin group (30 weeks: 0.9 versus 1.2, P value = 0.032; 40 weeks: 1.7 versus 2.1, P value = 0.002) (Figure 9 ). Figure 10 shows illustrations of superoxide anion levels in Shengjie Tongyu granule, simvastatin, and control groups at 30 weeks (A, B, and C) and 40 weeks (D, E, and F).
MOMA-2 Expression
Level. MOMA-2 expression levels increased with time in all groups, but increased significantly less in the simvastatin and Shengjie Tongyu groups than in the control group (30 weeks: 4.4 and 4.7 versus 5.6, 40 weeks: 5.0 and 4.8 versus 14.3, P values < 0.001). At 30 weeks, MOMA-2 expression in the Shengjie Tongyu group was higher than in the simvastatin group (4.7 versus 4.4, P value = 0.012) (Figure 11 ). Figure 12 shows illustrations of these changes.
NFκB P50 Expression. The NFκB P50 expression level increased with time in all groups, but was significantly lower in the simvastatin and Shengjie Tongyu groups than in the * Indicates a significant difference compared to the control group. § Indicates a significant difference compared to the 30-week group.
control group (30 weeks: 12.4 and 11.0 versus 14.0, 40 weeks: 2.9 and 2.7 versus 9.9, P values < 0.001). At 30 weeks, NFκB P50 expression in the Shengjie Tongyu group was significantly lower than in the simvastatin group (11.0 versus 12.4, P value < 0.001) (Figure 13 ).
Discussion
Shengjie Tongyu granule and simvastatin decreased both vascular remodeling and signs of vascular inflammationin ApoE-gene-knockout mice fed a high fat diet. However, * Indicates a significant difference compared to the control group.
† Indicates a significant difference compared to the simvastatin group. § Indicates a significant difference compared to the 30-weeks group. treatments, while the other three markers remained at 75 to 85% of control levels. At 40 weeks, a more chronic stage of atherosclerosis, ICAM-1 levels remained at about 80% of control, but MOMA-2 and NFκB levels in treated animals dropped to 34% and 28% of control, that is, inhibition of these markers became similar to the inhibition of superoxide anion. Atherosclerosis is a chronic inflammatory process, and the inflammatory cells involved produce a large amount of ROS during this process. ROS impairs cell functions, leading to the activation and expression of NF-κB. Studies have shown that ROS production and increased NF-κB expression occur during the early stage of atherosclerosis [17] . Then, as the development of atherosclerosis progresses and inflammation continues, ox-LDL produced from oxidized ROS may cause additional NF-κB activation. In our study, the reason that it took longer for the two treatments to decrease NF-κB levels than to decrease ROS might be because of the secondary ox-LDL effect.
Superoxide anions can activate downstream MAPKs, Janus kinase, STAT, and NF-κ [18] [19] [20] . The current results suggest that simvastatin and Shengjie Tongyu granule act by decreasing superoxide anion and in this way decrease NFκB. But the pathology leading to atherosclerosis in complex, and other pathways and mechanisms cannot be ruled out. Recently simvastatin was shown to decrease vascular remodeling by inhibiting the volume-operated chloride channel [21] , but this study was of vascular remodeling induced by hypertension, and may not be applicable to the model used here, that is, to vascular remodeling as a result of atherosclerosis. Our results on the actions of simvastatin in atherosclerosis are, however, consistent with those of others [5] .
Shengjie Tongyu granule depressed ICAM-1, superoxide anion, and NFκB slightly more and MOMA-2 slightly less than simvastatin. But in general, the actions of simvastatin and Shengjie Tongyu granule on each of the parameters studied were very similar. This result is somewhat surprising because simvastatin is a single defined chemical, and Shengjie Tongyu is composed of a number of components with different actions. This result could be explained logically if the two substances had identical effects on a single key instigating factor (such as superoxide anion), and the other phenomena observed were merely sequels to the initial action. Of course, only further study can determine whether this insight is true.
The present study offers a new understanding of the mechanism and targets for Shengjie Tongyu granule action in atherosclerosis that may be helpful in further development of methods for the prevention and treatment of vascular remodeling in atherosclerosis. In the future, we hope to investigate which specific compound in Shengjie Tongyu granule has the inhibitory effect on inflammation and vascular remodeling described here.
